Location: Home
  • search
  • go
  • Relate News
  • 11/15/2021SCMP: China May Approve First Covid-19 Drug Within Weeks
  • 11/12/2021CDE Issues the Technical Guidelines for Minimal Residual Disease Detec...
  • 11/12/2021NMPA Solicits Comments on the Draft Provisions for Quality Control of ...
  • 11/12/2021AZ Reports Mixed Q3/2021 Results, As It Begins to Manage Future Expect...
  • 11/11/2021NMPA Hosts Meeting on Drug, Medical Device, Cosmetic Regulation in Chi...
  • 11/11/2021Everest Med and Gilead Announce P2b Study of Sacituzumab Govitecan in ...
  • 11/11/2021Organon Reports Q3/2021 Earnings, Highlighting China Performance
  • 11/11/2021Blueprint Medicines and Zai Lab Announce License Deal for BLU-945 and ...
  • 11/11/2021Karuna Therapeutics and Zai Lab Announce Strategic Partnership for Ka...
  • 11/11/2021Beijing Intellectual Property Court Accepts China's First Drug Patent ...
  • 11/11/2021China Clears Trials on Using mRNA Vaccine as Booster Shot
  • 11/11/2021SK Biopharm Establishes Biotech Company in China
  • 11/11/2021AffaMed Launches Digital Medicines Unit
  • 11/11/2021PharmExec: China 2021 National Reimbursement Drug List Outlook (Update...
  • 11/11/2021How Hong Kong Plays a Central Role in The Biotech Investment Boom
  • 11/10/2021South China Province Plans $94 Million HPV Vaccination Pilot Program
  • 11/10/2021NDRC and MIIT Jointly Issue the Implementation Plan for Promoting High...
  • 11/10/2021Eli Lilly's Chinese NDA for RET Inhibitor Selpercatinib Accepted
  • 11/10/2021CDR Solicits Comments for the Proposed Guidelines for Preparing Drug P...
  • 11/10/2021CPhI Survey: US Pharma Growth to Exceed Both India and China in 2022
  • 11/10/2021Merck KGaA Veteran Launches I/O Startup Marengo Therapeutics with $80M
  • 11/9/2021Biosynth Carbosynth and Shengquan Acquire Kexing Biopharma's API Plant
  • 11/9/2021PhIIC Reports Topline 2020 Data of Chinese Pharmaceutical Market
  • 11/9/2021HUYABIO Announces the Exclusive License of the Wee1 Inhibitor from Sha...
  • 11/9/2021China Reports Progress of New COVID-19 Antibody Drugs
  • 11/9/2021Incidence of Guillain-Barré Syndrome (GBS) in China: A National Popul...
  • 11/8/2021I-Mab and Roche Diagnostics Announce Strategic Collaboration to Co-Dev...
  • 11/8/2021Ascentage and Pfizer Enter Clinical Trial Agreement to Evaluate Lisaft...
  • 11/8/2021NHC Issues Action Plan to Improve Child Health
  • 11/8/2021Half of Top 20 Pharma MNCs Participate CIIE, Showing Continued Commitm...
  • Page:177/789 Total number of articles:23668: [First][<<] [175] [176] [177] [178] [179] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group